|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) |
| (11) | Number of the document | 3218487 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15794804.3 |
| Date of filing the European patent application | 2015-11-10 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/059958 |
| Date | 2015-11-10 |
| (87) | Number | WO 2016/077349 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 201462077799 P | 2014-11-10 | US | |
| 201462077672 P | 2014-11-10 | US | |
| 201562137464 P | 2015-03-24 | US |
| (72) |
HINKLE, Gregory , US
JADHAV, Vasant , US
MAIER, Martin , US
MANOHARAN, Muthiah , US
MILSTEIN, Stuart , US
SHULGA-MORSKAYA, Svetlana , US
RAJEEV, Kallanthottathil G. , US
SEPP-LORENZINO, Laura , US
XU, Huilei , US
|
| (73) |
Alnylam Pharmaceuticals, Inc. ,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | HEPATITIS D VIRUS (HDV) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| HEPATITIS D VIRUS (HDV) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |